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Dysfunction of peroxisome proliferator-activated receptor gamma coactivator-1alpha
(PGC-1α) has been linked to various neurodegenerative and neuropsychiatric disorders;
however, reports on psychic behavioral alterations on PGC-1α-deficient animals are
sparse. The present study revisited prior observations of anxiety-related, depression-
related, and hippocampal memory-related observations having been made on different
PGC-1α-deficient murine strains, in a large-scale analysis on whole-body full-length
(FL-)PGC-1α-deficient mice. The examinations were performed on animals covering
a wide age range enrolled from both sexes, and included paradigms such as
the open-field, elevated plus maze, light-dark box, tail suspension test, and spatial
recognition two-trial Y-maze. The findings revealed no signs of previously reported
anxiety-like behavior, but revealed an unexpected phenotype with decreased anxiety
behavior consistent throughout different paradigms, with slight male preponderance.
This was associated with despair-like anhedonic behavior, consistent with that reported
previously, but did not associate with either peripheral or brain alterations in kynurenic
acid synthesis, which was previously proposed. Though male FL-PGC-1α-deficient mice
tended to perform poorer in the hippocampus-based spatial learning paradigm, the
genotype overall was not associated with impairment in spatial memory, contradicting
with prior observations. None of the observed alterations deteriorated with age, similarly
to motor alterations as reported previously. The most likely contributors of this peculiar
phenotype are discussed, with clinicopathological correlations drawn. Being the first to
address these behavioral domains within the same PGC-1α-deficient strain, our findings
extend the knowledge about the complex in vivo effect of PGC-1α dysfunction and add
important notes to research in the field of PGC-1α in connection with neuropsychiatric
disorders.
Keywords: anxiety, behavior, depression, memory, peroxisome proliferator-activated receptor gamma
coactivator, PGC-1α
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INTRODUCTION
Peroxisome proliferator-activated receptor gamma (PPARγ)
coactivator-1alpha (PGC-1α), a widely studied metabolic master
regulator protein, is responsible for the coactivation of a
number of nuclear transcriptional factors that in turn enhance
the expression of several genes involved in the promotion of
mitochondrial adaptive biogenesis, oxidative phosphorylation,
and oxidative stress defense (Szalardy et al., 2015). In addition
to its role in diseases related to fat and glucose metabolism
(Wu et al., 2016), the deficient function of PGC-1α has
been implicated in the pathogenesis of various CNS diseases,
especially where defective mitochondrial function has been
described as one of the key pathogenic factors, such as in
HD, AD, PD, and MND (Rona-Voros and Weydt, 2010;
Szalardy et al., 2015). Furthermore, increasing evidence indicate
a potential role of PGC-1α in various psychiatric disorders,
including schizophrenia (McMeekin et al., 2016) and depression
(Agudelo et al., 2014). Several studies with a number of
different molecular genetic approaches have been published
phenotyping different PGC-1α-deficient murine strains in the
past decade (i.e., complete/incomplete whole-body, organ- or
cell type-specific, and conditional/germline knockout strains).
These together delineated a phenotype rather reminiscent of a
mitochondrial disease, with prominent spongiform intramyelin
brain vacuolation, brainstem and cerebellar gliosis, and Purkinje
cell loss in the CNS, accompanied by mild myopathic changes
in the skeletal muscle (Lucas et al., 2012, 2014b; Szalardy
et al., 2013, 2016a,b). These neuropathological hallmarks are
accompanied by reduced locomotion, muscle weakness, and
ataxia (Lucas et al., 2012, 2014b; Szalardy et al., 2016a), a motor
phenotype intriguingly not found to progress with age (Lucas
et al., 2012; Szalardy et al., 2016a). Despite the fact that most
of the above listed human CNS disorders associate with non-
motor features, only few studies have so far addressed non-motor
phenotypic alterations in PGC-1α-deficient animals, providing in
part contradictory results from different knockout strains, with
each focusing on particular aspects (Leone et al., 2005; Agudelo
et al., 2014; Lucas et al., 2014a; Bartley et al., 2015). On the
basis of this, our current study aimed at revisiting anxiety-related
behavior (by means of three independent methods), depression-
related behavior, and visuospatial memory in relatively large
cohorts of whole-body full-length (FL-)PGC-1α-deficient mice,
with special focus on the potential influence of age and sex.
Based on the recent findings of altered expression of KATs (the
enzymes responsible for KYNA synthesis) in PGC-1α-deficient
and transgenic PGC-1α-overexpressing tissues and its proposed
Abbreviations: AD, Alzheimer’s disease; BBB, blood–brain barrier; CNS, central
nervous system; EPM, elevated plus maze; FLD, fluorescence detector; FL-
PGC-1α, full-length PGC-1α; GR, glucocorticoid receptor; HD, Huntington’s
disease; HPLC, high-performance liquid chromatography; IL, interleukin; KAT,
kynurenine aminotransferase; KYNA, kynurenic acid; LDB, light-dark box;
LEM6, ligand effect modulator 6; MND, motor neuron disease; NT-PGC-1α,
N-terminal fragment of PGC-1α; OF, open-field; PD, Parkinson’s disease; PEPCK,
phosphoenolpyruvate carboxykinase; PGC-1α, PPARγ coactivator-1alpha; PPARγ,
peroxisome proliferator-activated receptor gamma; PV, parvalbumin; QUIN,
quinolinic acid; TNFα, tumor necrosis factor alpha; TRP, tryptophan; TST, tail
suspension test.
role in the anhedonic phenotype of muscle-specific PGC-1α
deficient mice (Agudelo et al., 2014), an additional focus has
been placed on the qualitative analysis of KYNA production
in different tissues and brain regions of FL-PGC-1α-deficient
mice. Our results reveal an intriguing fearless but depressive-
like phenotype of non-progressive nature, with no overt signs
of hippocampal memory involvement and no evidence for
an altered KYNA synthesis. The potential clinicopathological
correlations are discussed.
MATERIALS AND METHODS
Behavioral Analysis
Animals
For behavioral studies, male and female FL-PGC-1α −/−
(n = 26–37 per cohort) and C57Bl/6J wild-type (n = 34–42 per
cohort) mice were used. These knockout mice (Leone et al., 2005)
lack the expression of the FL-PGC-1α protein but express an
N-terminal fragment of 254 amino acids (Chang et al., 2012),
and have recently been comprehensively characterized in terms
of neuropathological alterations and motor phenotype (Szalardy
et al., 2013, 2016a,b). Similarly to that reported before (Szalardy
et al., 2016a), the experimental animals of each study cohort
were randomized from a population ranging through a wide
spectrum of age (12–91 w, overall medians: 48.6 w FL-PGC-1α
−/− vs. 47.9 w wild-type) to create age- and sex-matched wide-
age-range cohorts. The FL-PGC-1α −/− mice strain developed
on C57Bl/6J background were originally generated in the Kelly
Lab (Sanford-Burnham Institute for Medical Research at Lake
Nona, Orlando, FL, United States) and the founders of the FL-
PGC-1α −/− and +/+ populations bred in our institute were a
kind gift from Albert C. Ludolph and Patrick Weydt from the
Department of Neurology, University of Ulm, Ulm, Germany,
as littermates born from +/− breeding pairs. The genotyping
of these animals was carried out as previously described by
Leone et al. (2005). Keeping in mind the previously reported
unexpected loss of PGC-1α −/− pups (Lin et al., 2004), in
order to achieve sufficient subject numbers for the large-scale
analyses, the experiments were conducted on first-, second-,
and third-generation offsprings of FL-PGC-1α −/− and +/+
populations resulted from homozygous × homozygous mating
of the founders, bred under identical conditions, within the
same room, handled by the same staff. The animals were
housed in cages (maximum 4 per cage) in standard conditions
with 12–12-h light-dark cycle and free access to water and
standard pellet food. Three wide age-range-cohorts were created
to assess anxiety-related behavior, depressive-like behavior, and
visuospatial memory, respectively (the general characteristics of
the experimental cohorts are presented in Table 1). The animals
were placed in a transport room localized in the immediate
vicinity of the experimental room 12 h before the behavioral
assessments in order to adapt to the experimental conditions.
The animals were examined during the same time of the day to
minimize the bias of diurnal rhythm. The experimental setups
were thoroughly wiped using a solution containing 30% ethanol,
and were allowed to dry completely following every single
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experimental session to prevent bias raising from olfactory cues.
Standard light and temperature conditions were provided during
the study. The experiments complied with the EU Directive
2010/63/EU for animal experiments and were approved by the
local Animal Care Committee.
Anxiety-Related Behavior
To assess potential anxiety-related behavioral alterations,
the experimental animals were examined by three different
experimental modalities: the OF test, the EPM test, and the LDB
test.
The OF test was performed to assess the propensity of
the animals to avoid the central zone of the setup (a.k.a.
thigmotaxis), an anxiety-related feature previously described to
be characteristic of this strain (Leone et al., 2005). The setup
comprised a black box with a wall height of 36 cm and an open
ambulatory field of 48∗48 cm. The experiments were performed
under indirect dim light (2.5 lux). The study animal was placed
into the center of the field and allowed to spontaneously explore
for a duration of 30 min. The pattern of locomotion was
recorded by infrared led beams and automatically analyzed by
the Conducta 1.0 software linked to the setup (Conducta 1.0
System, Experimetria Ltd., Hungary). In a symmetrical 9-square
division (3 × 3 square grid), the relative time spent in the 8
peripheral zones altogether (peripheral/total time %) were used
for the statistical analysis as a measure of thigmotaxis. Ancillary
parameters such as rearing time (s) and total distance ambulated
(cm) were used to validate the findings by comparing to prior
results with this strain.
The EPM test was performed on the same cohort 4 weeks after
the OF test. The maze comprised four arms of 35 cm in length
and 10 cm in a width, with two opposing arms enclosed from the
sides by black walls of 20 cm in height (closed arms), whereas the
other two arms remained unclosed (open arms). The floor of the
maze was covered with white plastic film and was located 50 cm
above the floor of the room. The whole setup was encompassed by
a white belt of 90 cm in height and 120 cm in diameter to create a
homogeneous bright arena with no visual bias. The examination
was performed under standard diffuse bright light intensity
conditions (800 lux). The mice were put in the central area (with
head to an open arm distal from the examiner) and let freely
explore for 5 min. The locomotion pattern of the animal was
tracked and recorded by a video-associated behavioral tracking
system (SMART v2.5, Panlab, Spain). The percentage of the time
spent in the closed arms (%) was used for statistical analysis.
Ancillary parameters included the total distance ambulated (cm)
and the distances ambulated in the open or closed arms relative to
the time spent within them (cm/s; open velocity, closed velocity).
The LDB test was performed 10 days after the EPM. The
apparatus consisted of a 20∗30-cm chamber open from above
and a 20∗20-cm fully covered chamber, interconnected with a
6∗6-cm orifice. The experiment was conducted under bright light
intensity conditions (1650 lux in the light chamber, <3 lux in
the dark chamber). The animal was placed in the light chamber
and let freely explore for 3 min. The motion of the experimental
animal was tracked by the Smart v2.5 system (Panlab), and
the relative time spent in the dark chamber (%) was used for
statistical analysis. Ancillary parameters included the distance
ambulated in the light chamber relative to the time spent within
the light chamber (cm/s; light velocity).
Depressive-Like Behavior
The TST, a widely used behavioral paradigm of despair, was used
to assess a potential depression-related behavioral alteration due
to whole-body FL-PGC-1α deficiency in another study cohort
of animals. The examined animal was hanged by the tail with a
special clip developed to achieve a firm but soft and pain-free
fixation, and were placed into a 40∗30∗20-cm box. We used a
cone-shaped shield to prevent climbing behavior. The tracking
duration of 3 min was shorter than the commonly applied 5–
6 min to minimize the bias due to decreased endurance. The
box was lit from behind through an opaque translucent wall,
resulting in a diffuse light inside the closed box. The animals
TABLE 1 | Description of experimental cohorts used to asses different behavioral domains.
FL-PGC-1α −/− Wild-type p
Anxiety
n= 26 34 –
Female/male 14/12 17/17 0.768
Age w 39.8 [17.9–51.1] 39.7 [21.9–62.5] 0.627
Younger/older 13/13 17/17
Despair
n= 37 42 –
Female/male 18/19 20/22 0.927
Age w 54.9 [27.6–71.9] 56.0 [45.6–71.6] 0.420
Younger/older 17/20 19/23
Spatial memory
n= 30 30 –
Female/male 15/15 15/15 1.000
Age w 45.9 [20.1–51.9] 42.0 [41.9–64.1] 0.477
Younger/older 14/16 15/15
w, weeks.
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were observed and rated by the experimenter using a video-
observer system that recorded the animals through a small hole
in the wall of the box, with its size corresponding to that of
the lens of the camera. Total time spent in immobility (s)
was measured by the experimenter using a stopwatch, and was
used for statistical analysis. The animals in this cohort were
phenotyped for grip strength 3 months prior to the TST with a
method previously described (Szalardy et al., 2016a), and based
on the non-progressive feature of weakness in these mice, its
measure was used to control for the potential confounding effect
of muscle weakness in the observed immobility.
Visuospatial Memory
To assess the visuospatial memory performance of FL-PGC-1α
−/− mice, the standard two-trial spatial Y-maze test was used,
with slight modifications. The method takes advantage of the
innate propensity of mice to prefer the novel environment during
spontaneous exploration. The maze consisted of a long arm (with
a length of 45 cm) that continued in two short arms (with lengths
of 36–36 cm) that were perpendicular to each other and made
135–135◦ angles with the long arm, symmetrically. All three arms
were 12 cm in width and were enclosed by transparent plastic
walls of 30 cm in height. The maze was located on a board fully
encompassed by black walls of 70 cm in height to create an
isolated visual environment for the maze. The three arms of the
maze were surrounded by unique 2D and 3D visual cues using
black and white patterns. A standard dim light was applied during
the experiment (70 lux). The activity of the animal was tracked by
the Smart v2.5 system (Panlab). The two-trial test comprised an
acquisition trial and a recognition trial. During the acquisition
trial, the animal was placed into the end of the long arm with
head to the wall and were allowed to freely explore the long arm
and one of the short arms, with the other one being closed at
entry (the animals were randomly assigned to be ‘left-sided’ or
‘right-sided’). The acquisition trial was stopped manually when
the study animal spent a total of 2 min within the open short
arm. After an inter-trial interval of 30 min, the recognition trial
was initiated, where both short arms were open for exploration.
The tracking was stopped after the animal reached a total time of
2 min spent in the (known and the novel) short arms together.
The ratio of the distance traveled in the novel short arm versus
that in both the novel and the known short arms (i.e., recognition
distance index) were used for statistical analysis.
Histological Work-Up
To assess potential between-sex differences in terms of hallmark
neuropathological alterations, 4-µm-thick sagittal sections of
paraffin-embedded brain halves of 7 female and 8 male FL-PGC-
1α-deficient mice sacrificed at 30 w of age were evaluated in
different levels. We did not use wild-type specimens for this
between-sex analysis as they do not demonstrate pathological
vacuolation at this age (Szalardy et al., 2013). We also did not use
older animals as myelin vacuolation is part of the ‘physiological’
aging which may serve as a bias for analysis. Various brain regions
were evaluated for myelin vacuolation, a core neuropathological
feature of PGC-1α-deficient mice, by means of a semi-
quantitative method described previously (Szalardy et al., 2013).
In brief, Hematoxylin-Eosin and Klüver–Barrera (Luxol and Fast
red) stainings were used for the evaluation with the following
semi-quantitative scoring scheme used at 40× magnification
under the light microscope: (0) No vacuolation: ≤1 vacuole-like
alteration per visual field; (1) Scattered vacuolation; 2–3 vacuoles
per visual field; (2) Mild vacuolation: 4–10 vacuoles per visual
field; (3) Moderate vacuolation: 11–20 vacuoles per visual field;
(4) Severe vacuolation:>20 vacuoles per visual field.
HPLC Measurements
High-performance liquid chromatography (HPLC) was used for
the quantitative analyses of TRP and KYNA levels in different
murine tissues. The tissue specimens were obtained immediately
after decapitation on ice, and kept in sterile polypropylene tubes
at −80◦C until homogenization. Liver samples of 16 wild-type
and 15 FL-PGC-1α-deficient female and male mice and samples
of different brain regions of particular involvement in PGC-
1α-deficiency (striatum and cerebellum) of 8 wild-type and 6
FL-PGC-1α-deficient male mice were used for the analysis. On
the basis of previously reported alterations of TRP levels in the
brain in rats (Carlsson and Carlsson, 1988) and mice (Kim et al.,
2005) (with female animals having been reported to have slightly
though significantly higher levels), only male tissues were used
for the analysis of brain specimens. The specimens were weighed
and then homogenized for 1.5 min in 250 µl freshly prepared
ice-cold solution, containing trifluoroacetic acid (0.1% v/v) and
2 µM 3-nitro-L-tyrosine (3-NLT), as internal standard. The
homogenates were centrifuged at 13709 RCF (12000 RPM) for
10 min at 4◦C. The resulting supernatants were stored at −80◦C
until further use. Subsequently, the supernatants were measured
with an Agilent 1100 HPLC system (Agilent Technologies,
Santa Clara, CA, United States) combined with a fluorescence
(FLD) and a UV detector. The FLD was set at excitation and
emission wavelengths of 254 and 398 nm; and 344 and 398 nm,
respectively, for the quantification of TRP and KYNA. The UV
detector was set at 365 nm for the determination of 3-NLT.
Chromatographic separations were performed on a Kinetex C18
column, 150∗4.6 mm I.D., 5-µm particle size (Phenomenex Inc.,
Torrance, CA, United States) preceded by a Security Guard pre-
column C18, 4∗3.0 mm I.D. (Phenomenex Inc.). The mobile
phase, containing 0.2 M zinc acetate/ACN = 95/5 v/v%, in which
pH was adjusted to 6.2 with acetic acid, was delivered at a flow
rate of 1.2 ml/min. The injection volume was 50 µL. As for the
validation of the method, the following parameters are reported,
briefly, regarding TRP and KYNA. The limit of detection (LOD)
and lower limit of quantification (LLOQ) were 10 and 0.4 nM;
and 20 and 1 nM, respectively. With regard to precision, the
relative standard deviations for the peak area response was
≤2.2%, whereas for the retention time it was ≤0.1%, for both
the investigated compounds. The recoveries for the brain samples
ranged from 86 to 91% and 82 to 92% for TRP and KYNA,
respectively.
Statistical Analysis
The statistical analysis was performed by SPSS 22.0 software
(SPSS Inc., Chicago, IL, United States). The distribution of the
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variables within each study dataset was assessed by the Shapiro–
Wilk test. Variables with normal distribution were analyzed
by parametric, whereas those with non-normal distribution by
non-parametric tests. Parametric comparative analysis between
two groups was performed by Student’s unpaired t-test using
also the Levene’s test to assess the equality of variances
and the Welch’s correction where appropriate. Non-parametric
comparative analysis between two groups were performed by
the Mann–Whitney U test. Correlation analyses were subjected
to Pearson’s correlation or Spearman’s rank correlation for
variables with normal and non-normal distribution, respectively,
with p-values corrected for the number of variables within
the analysis to avoid family wise error. When controlling
the analyses for potential confounders (e.g., age, sex, grip
strength performance, and/or body weight), the estimation
of the effect sizes of variables were performed by binary
logistic regression analyses. On assessing phenotypic progression,
subgroups of the younger and older animals were analyzed
(split at the median, with subjects having an age corresponding
to the median regarded consistently as old; Table 1). Multiple
comparisons of pre-defined subgroups based on age or sex
were performed by one-way analysis of variance (ANOVA) or
one-way Kruskal–Wallis test, depending on the distribution
of the data, followed by pairwise corresponding post hoc
analyses with p-values corrected for multiple comparisons
with the Bonferroni method. The significance of novel place
recognition in the Y-maze was tested by the one-sample t-test
or the one-sample Wilcoxon signed rank test in the case of
normal or non-normal distribution, respectively, setting the
reference level to 50% (i.e., zero preference). The analysis of
discrete variables obtained from the semi-quantitative scoring of
histological preparations were performed by the Fisher’s exact
test. Data are presented as mean (± standard error of mean)
or median [interquartile range] for variables with normal and
non-normal distribution, respectively. A p-value less than 0.05
was regarded as significant. Data of behavioral analyses in
Figure 1 are presented in box plots separately for sexes that are
superimposed by the box plot of the corresponding pooled data,
enabling the visualization of sex- and genotype-related effects,
respectively.
RESULTS
Assessment of Anxiety-Related Behavior
Three consecutive experiments with different behavioral
modalities were performed to assess potential anxiety-related
alterations in FL-PGC-1α −/− mice. In the pooled analysis, the
OF test revealed no significant differences between FL-PGC-
1α −/− and wild-type mice in terms of their propensity to
avoid the central zone (p = 0.092; 87.3% [82.9–92.9%] vs. 85.3
[83.6–87.9%]; Figure 1A), indicating no signs of thigmotaxis.
Likewise, the peripheral/total time % was not a significant
predictor of the genotype in the binary logistic regression
analysis controlling for age and sex [p = 0.133, Wald = 2.258,
Exp(B) = 0.922 (95% confidence interval (CI) = 0.830–1.025]. No
significant differences were found either between sexes within
genotypes or between genotypes within sexes (p > 0.05 for all
post hoc analysis). This measure did not correlate with age and
no differences were found between young and elderly subgroups
in either genotype (p > 0.05 for all). In the pooled analysis, the
OF paradigm also revealed significantly decreased ambulation
distance and rearing time in FL-PGC-1α −/− mice (p < 0.001
for both ancillary variables), with effect sizes in the logistic
regression analyses controlled for age and sex being comparable
to that reported in our prior publication [ambulation distance:
p < 0.001, Wald = 13.078, Exp(B) = 1.0007 (95% CI = 1.0003–
1.0010); rearing time: p < 0.001, Wald = 11.529, Exp(B) = 1.028
(95% CI = 1.012–1.045)], recapitulating previous findings
(Szalardy et al., 2016a).
Having demonstrated no signs indicative of thigmotaxis,
the cohort was subjected to paradigms being more specific
for anxiety. Intriguingly, the pooled analysis of the EPM
paradigm not only failed to detect anxiety in FL-PGC-1α −/−
compared to wild-type mice, but demonstrated significantly less
anxiety-related behavior in this genotype compared to wild-
type (closed/total time %: p < 0.001, 52.7% [33.4–67.6%] vs.
70.5% [59.5–77.8%]; Figure 1B). The effect of this variable in
predicting the genotype was highly significant when controlled
for age and sex [p < 0.001, Wald = 10.689, Exp(B) = 1.068
(95% CI = 1.027–1.111], corresponding to a 6.8% increase
in the odds of being wild-type with every additional %
elevation in the relative time spent in the closed arms. This
difference between genotypes tended to be more pronounced
among male mice (p = 0.008), having lost significance among
females following Bonferroni correction (p = 0.176). A similar
dichotomy was reflected also by the different effect sizes obtained
from sex-wise logistic regression analyses controlled for age
[p = 0.032, Wald = 7.052, Exp(B) = 1.079 (95% CI = 1.020–
1.142) for males; p = 0.264, Wald = 3.379, Exp(B) = 1.058
(95% CI = 0.096–1.124) for females]. Within FL-PGC-1α −/−
mice, this low-anxiety feature was significantly more pronounced
in male mice compared to females (p = 0.017), with no such
between-sex difference observed among wild-types (p = 0.424).
However, due to a substantial overlap between the 95% CI of
the Hodges–Lehman estimators of the median of difference,
the difference between the observed differences in a given
comparison (irrespectively of whether they are in fact significant
or not) is not statistically significant at α = 5%; therefore, we
cannot draw firm conclusions on either the male-specificity
of the observed between-genotype difference or the genotype-
specificity of the between-sex difference. As regards phenotypic
progression, no significant correlation was observed with age
in any groups, along with no significant differences between
young and elderly subgroups (p > 0.05 for all), indicating
a non-progressive nature of the observed alteration in FL-
PGC-1α −/− mice. Differences regarding ancillary measures
such as total and time-relative distances ambulated (i.e.,
‘velocities’) were not statistically significant between genotypes
(not shown).
This pattern was almost completely recapitulated by a
subsequent experimental paradigm in the LDB performed with
the same cohort, revealing significantly less relative time spent
in the dark chamber in FL-PGC-1α −/− mice compared to
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FIGURE 1 | Assessment of psychomotor alterations of FL-PGC-1α-deficient mice. The OF did not reveal signs of thigmotaxis (A), with the EPM (B) and LDB (C)
consistently demonstrating decreased anxiety, with a tendency to be driven predominantly by males. The assessment of despair in the TST revealed significantly
increased immobility time irrespective of sex (D), with no evident correlation with muscle strength (not shown). The 2-trial asymmetric spatial recognition Y-maze
revealed no overall impairment in spatial memory in FL-PGC-1α-deficient mice, with only a tendency for males to be slightly affected (E). ∗p < 0.05; ∗∗p < 0.01;
∗∗∗p < 0.001; #p < 0.065 (regarded as a non-significant trend).
wild-type animals (dark/total time %: p < 0.001, 46.1% [13.5–
64.6%] vs. 78.2% [66.8–85.2%]; Figure 1C). This variable was
also a strong predictor of genotype when controlled for age and
sex, with a similar effect size to that of the closed/total time
% in the EPM [p < 0.001, Wald = 15.532, Exp(B) = 1.076
(95% CI = 1.038–1.116)], corresponding to a 7.6% increase in
the odds of being wild-type with every additional % elevation
in the relative time spent in the dark. The difference between
genotypes was consistent and significant in both sexes even after
Bonferroni correction (p = 0.004 for both sexes), with comparable
effect sizes when controlled for age [p = 0.020, Wald = 7.839,
Exp(B) = 1.064 (95% CI = 1.019–1.111) for males; p = 0.025,
Wald = 7.491, Exp(B) = 1.096 (95% CI = 0.126–1.170) for
females]. In this case, no significant between-sex differences
were observed in either the FL-PGC-1α −/− (p = 0.192) or
the wild-type subcohorts (p = 0.292). No significant correlation
was observed with age in any groups, along with no significant
differences between young and elderly subgroups (p > 0.05
for all), likewise indicating a non-progressive alteration in FL-
PGC-1α −/− mice. The analysis of ancillary measures revealed
significantly decreased ambulation distance relative to the time
spent in the light chamber (light velocity) in FL-PGC-1α −/−
mice compared to wild-types [p < 0.001, 3.2 (±0.3) cm/s vs. 5.0
(±0.3) cm/s] irrespective of sex.
To estimate the concordance of the observed data within the
total experimental cohort, correlation analyses were performed
by the use of the core variables of the three anxiety-
related measures. These revealed that the performance of
the animals in the EPM (closed/total time %) significantly
correlated with that in the LDB (dark/total time %; p = 0.012,
Spearman’s Rho = 0.386), whereas the peripheral/total time
% the OF (as a measure of thigmotaxis) did not correlate
with either variables (p = 1.000, Spearman’s Rho = 0.035
with closed/total time %; p = 1.000, Spearman’s Rho = 0.021
with dark/total time %). Furthermore, ancillary parameters
of general ambulatory behavior (absolute distances traveled
during tracking) measured along the different modalities were
significantly and remarkably strongly concordant among FL-
PGC-1α −/− animals (but not among wild-types), with
the majority demonstrating significant correlations with the
strongest low-anxiety parameter (dark/total time %) as well
(Supplementary Table S1).
Controlling for the potential though unlikely bias of general
hypomotility underlying a specific regional preference, we found
that the effect sizes of the EPM and LDB outcomes did not
significantly change when potential confounder variables from
either independent (ambulation distance from the OF) or
dependent modalities (total distances ambulated in the EPM or
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in the light chamber of LDB) were controlled for in a variety of
binary logistic regression models alone or in combination.
Assessment of Depressive-Like Behavior
The pooled analysis of the TST paradigm revealed significantly
more time spent in immobility in FL-PGC-1α −/− mice
compared to wild-type animals [p < 0.001, 67.5 (±3.2) s vs.
45.0 (±2.8) s, Figure 1D]. The variable was a strong predictor
of genotype when controlled for age and sex, [p < 0.001,
Wald = 16.378, Exp(B) = 0.936 (95% CI = 0.907–0.967)],
corresponding to a 6.4% decrease in the odds of being wild-
type with every additional s elevation in the time spent in
immobility. The difference between genotypes was consistent
and significant in both sexes even after Bonferroni correction
(p = 0.007 for males, p = 0.001 for females), with comparable effect
sizes as a significant predictor of the genotype when controlled
for age [p < 0.005 for both; Exp(B) = 0.939 and 0.930 for
males and females, respectively]. In this case, no significant
between-sex differences were observed in either the FL-PGC-
1α −/− (p = 1.000) or the wild-type subcohorts (p = 0.304).
No significant correlation was observed with age in any groups,
along with no significant differences between young and elderly
subgroups (p > 0.05 for all), indicating a non-progressive
alteration in FL-PGC-1α −/− mice. Within the FL-PGC-1α
−/− genotype, the performance in the TST did not show
a significant correlation with their prior performance in the
inverted screen (p = 1.000, Spearman’s Rho =−0.045), suggesting
that the observed immobility behavior is not merely attributable
to decreased endurance, a feature characteristic of these animals.
Likewise, the entry of this variable did not significantly influence
the effect size of immobility time in predicting the genotype,
similarly to weight, which was not significantly different between
groups in the present analysis (not shown).
Assessment of Visuospatial Memory
Performance
The pooled analysis of the spatial Y-maze paradigm revealed
no significant difference in the recognition performance of FL-
PGC-1α −/− mice compared to wild-type animals (recognition
distance index %: p = 0.274, 60.9% [55.0–67.6%] vs. 64.0% [57.3–
72.0%]; Figure 1E). The variable did not predict the genotype
when controlled for age and sex either [p = 0.158, Wald = 1.990,
Exp(B) = 31.005 (95% CI = 0.263–3661.051)]. Both genotypes
significantly preferred the novel arm in the one-sample analyses
when pooled for sexes (p < 0.001 for both genotypes). In the
sex-wise analysis; however, male FL-PGC-1α −/− mice failed
to demonstrate significant preference (p = 0.061, median of
difference = 7.3%; 95% CI =−0.8–13.8%), while female FL-PGC-
1α−/−mice (p = 0.006) along with both the male (p = 0.005) and
the female (p < 0.001) wild-type subgroups demonstrated firm
recognition. Nevertheless, there were no statistically significant
differences between genotypes within sexes (including between
male FL-PGC-1α−/− and male wild-type mice) or between sexes
within genotypes (p > 0.05 for all). On the basis of the lack of
between-subgroup differences and that the observed data in male
FL-PGC-1α −/− mice is statistically consistent with a possible
true median recognition distance index % up to 63.8% (based on
the 95% CI), we cannot draw a firm conclusion on whether male
FL-PGC-1α−/−mice indeed have an impairment in visuospatial
memory. No significant correlation was observed with age in any
groups, along with no significant differences between young and
elderly subgroups (p> 0.05 for all).
Between-Sex Histopathological Analysis
Observing tendencies in the EPM and in the Y-maze paradigms
for FL-PGC-1α −/− males to be slightly more affected,
supplementary histopathological semi-quantitative comparative
analysis was performed between sexes as regards the extent of
myelin vacuolation, a core neuropathological alteration in PGC-
1α −/− mice, in various brain regions. The results revealed
no statistically significant differences in any examined brain
regions, revealing at most non-significant tendencies for a
male preponderance especially in the pontomedullary brainstem
and the motor cortex in the region-wise analysis; however, a
nominally significant though rather slight overall difference could
be detected between the mean vacuolation scores of all analyzed
brain regions in the pooled analysis, suggesting a minimal overall
predominance in males (2.3 ± 0.1 vs. 2.1 ± 0.1, p = 0.036). The
detailed findings are summarized in Table 2.
Measurement of KYNA and TRP Levels
On the basis of a prior report on altered KAT expression
in muscle-specific PGC-1α-deficient and transgenic PGC-1α
overexpressing mice (Agudelo et al., 2014), HPLC analysis of
KYNA and TRP was performed in liver, cerebellar, and striatal
specimens. The results demonstrate no significant differences
between groups in either metabolites or the KYNA/TRP ratio in
any examined tissues, and are summarized in Table 3.
DISCUSSION
A number of reports have been published describing certain
aspects of locomotor alterations in PGC-1α-deficient mice, and
recently, comprehensive works have together circumscribed a
motor phenotype of decreased locomotion, muscle weakness,
and ataxia, in association with the absence of either PGC-1α
or FL-PGC-1α in systemic and CNS-specific knockouts (Lucas
et al., 2012, 2014b; Szalardy et al., 2016a). Despite the fact that
PGC-1α-deficiency has been linked to various neurodegenerative
disorders that are associated with psychic alterations (Rona-
Voros and Weydt, 2010; Szalardy et al., 2015) and also with
schizophrenia (Jiang et al., 2013; McMeekin et al., 2016) and the
fact that a GWAS study has linked the chromosomal localization
of the PGC-1α gene (PPARGC1A, 4p15.1-2) to schizophrenia
and bipolar disorder (Christoforou et al., 2007), only a few
studies have addressed psychic behavioral alterations in the
literature. In addition, these dealt only with specific aspects,
such as anxiety-related behavior (Leone et al., 2005), depression-
related behavior (Agudelo et al., 2014), and certain hippocampal
functions (Lucas et al., 2014a; Bartley et al., 2015), and the
analyses were performed in different PGC-1α knockout strains,
evaluating either only males or females and males in a pooled
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TABLE 2 | Assessment of between-sex differences in the semi-quantitative scores
of brain vacuolation in FL-PGC-1α-deficient mice in selected brain regions.
Vacuolation Male Female p
Anterior Commissure 2.9 ± 0.3 2.1 ± 0.1 0.152
Hippocampusmed 1.0 ± 0.3 1.3 ± 0.3 1.000
Hippocampuslat 1.9 ± 0.5 2.0 ± 0.0 1.000
Thalamusmed 2.5 ± 0.3 1.6 ± 0.2 0.236
Thalamuslat 3.5 ± 0.3 3.6 ± 0.2 1.000
Nucleus accumbens 3.0 ± 0.4 2.1 ± 0.3 0.190
Mammillary body 1.7 ± 0.5 2.6 ± 0.3 0.592
Mesencephalonmed 2.4 ± 0.2 2.6 ± 0.3 1.000
Mesencephalonlat 3.0 ± 0.0 2.5 ± 0.5 0.333
Pontomedullary brainstemmed 3.3 ± 0.2 2.6 ± 0.2 0.058
Pontomedullary brainstemlat 2.1 ± 0.1 1.7 ± 0.5 0.054
Cerebellar cortexmed 0.3 ± 0.2 1.1 ± 0.2 0.125
Cerebellar cortexlat 0.3 ± 0.2 0.3 ± 0.2 1.000
Cerebellar nucleimed 2.3 ± 0.3 2.0 ± 0.0 1.000
Cerebellar nucleilat 2.3 ± 0.3 2.0 ± 0.4 1.000
Cerebellar white mattermed 1.8 ± 0.3 2.0 ± 0.2 0.765
Cerebellar white matterlat 2.0 ± 0.2 1.6 ± 0.4 0.648
Fasciculus retroflexus 4.0 ± 0.0 4.0 ± 0.0 1.000
Motor cortex 2.0 ± 0.0 1.4 ± 0.5 0.054
Sensory cortex 2.9 ± 0.1 2.3 ± 0.2 0.103
Visual cortex 2.6 ± 0.2 2.6 ± 0.2 1.000
Insular cortex 2.2 ± 0.2 1.8 ± 0.2 1.000
Striatum 4.0 ± 0.0 4.0 ± 0.0 1.000
Globus pallidus 2.7 ± 0.3 2.7 ± 0.3 1.000
Amygdala 1.4 ± 0.7 0.8 ± 0.3 0.420
Stria terminalis 2.7 ± 0.3 2.9 ± 0.3 1.000
Internal capsule 3.5 ± 0.2 3.7 ± 0.2 0.592
Fimbria hippocampi 1.8 ± 0.3 0.9 ± 0.3 0.273
Optic tract 0.3 ± 0.2 0.5 ± 0.3 1.000
Olfactory tract 2.0 ± 0.4 2.1 ± 0.3 0.767
manner (Table 4). As none of these findings have so far been
recapitulated in the literature and some of them have raised
intriguing questions, our aim was to revisit the observations of
anxiety-like behavior, despair, and hippocampal impairment in
whole-body FL-PGC-1α-deficient mice bred in our laboratory.
On the basis of prior findings that PGC-1α-deficiency-related
motor alterations appear to be non-progressive (Lucas et al.,
2012; Szalardy et al., 2016a) and the observations that the effect
of PGC-1α dysfunction tends to show a male preponderance
(Eschbach et al., 2013; Weydt et al., 2014), we performed our
analysis on large-subject-number cohorts covering a wide age
range, enrolling animals from both sexes in an age-matched
manner. An attempt is made to interpret the present data in light
of the literature reported on different PGC-1α knockout strains
with the inherent limitations considered and discussions made
accordingly.
Among the pioneering publications with PGC-1α-deficient
mice, Leone et al. (2005) reported the observation that their
whole-body PGC-1α knockout strain (today known as FL-PGC-
1α-deficient mice) demonstrated increased avoidance of the
central zone in the OF (a.k.a. thigmotaxis), a behavioral alteration
interpreted as increased anxiety. Analyzing the results of the 30-
min OF test in this current study, our first observation was that
FL-PGC-1α-deficiency was not associated with thigmotaxis in
any sex or age group. Core locomotor parameters were, however,
comparable to that reported previously (Szalardy et al., 2016a).
To further address this issue and to verify our results, after
abundant periods of recovery, the same cohorts of animals were
subjected to more specific tests of anxiety-related behavior, the
EPM and LDB. Interestingly enough, the EPM did not only fail
to reveal increased anxiety in FL-PGC-1α-deficient mice, but
demonstrated a significant decrease in anxiety-related behavior
in these animals, especially in males. This pattern was almost
completely recapitulated in the LDB.
Though it is unlikely that hypomotility per se could
concordantly skew the ambulation toward the preference of a
given type of area throughout different modalities, we addressed
the potential bias originating from hypomotility characteristic
of FL-PGC-1α-deficiency in a variety of logistic regression
models, revealing no significant influence on the overall effect
sizes. The lack of significant influence is also reflected by the
fact that hypomotility was not a statistically significant feature
of FL-PGC-1α-deficiency in the EPM paradigm (in terms of
total distance ambulated) contrasting with the OF and LDB
paradigms, still providing concordant results with the LDB
in terms of the assessed non-motor behavior. This is also
supported by the observation that FL-PGC-1α-deficient mice
not only spent less time in the closed arms in the EPM but
demonstrated significantly less closed/total distance ambulated as
well (not shown), which together with the lack of significantly
altered total ambulation distance in the whole setup directly
indicates a regional preference without evident hypomotility in
this particular paradigm.
To approach the not unprecedented phenomenon that PGC-
1α-deficiency tended to affect males more, we performed an
extensive sex-wise comparative histopathological analysis as
regards myelin vacuolation, a core neuropathological alteration
associated with PGC-1α-deficiency in the brain. The overall
comparison of subject-wise mean semi-quantitative scores of
every single brain region analyzed and scored revealed a
nominally significant though rather slight male predominance
of this alteration. The mean difference was most pronounced
in the pontomedullary brainstem; however, the scores did not
show statistical significance in the region-wise analysis due to
relatively high deviation. In the presence of a whole-body genetic
alteration that is associated with multiple systemic metabolic and
CNS-related alterations, an exact clinicopathological correlation
with the aim to explain a given phenotypic aspect usually
cannot be drawn, as most probably a constellation of endocrine,
metabolic, as well as structural and functional CNS alterations
can be accounted for the given phenotype. However, based
on the observation that the most devastatingly affected
structures include the fasciculus retroflexus (a.k.a. the habenula-
interpeduncular tract), one might speculate that the disruption
of the habenula-interpeduncular connection may at least in
part be attributable to the observation. Indeed, lesioning of
this pathway or the lateral habenula itself has been repeatedly
linked to decreased anxiety in rodents (Murphy et al., 1996;
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Pobbe and Zangrossi, 2008; Gill et al., 2013; Casarrubea et al.,
2015). Interestingly, lesions in this pathway have also been
associated with decreased maternal behavior (Matthews-Felton
et al., 1995), which is in accordance with our unpublished
impression about PGC-1α-deficient females, a phenomenon that
may also contribute to the remarkable loss of pups born otherwise
in normal average number in the litter (Lin et al., 2004).
As a next step of psychomotor phenotyping, we subjected
PGC-1α-deficient animals to the TST test, an established
animal model of despair. Our findings depict a clear increase
in immobility compared to age- and sex-matched controls,
irrespective of age. No significant between-sex difference was
observed in this case. These results nicely correspond with those
of a recent study revealing decreased sucrose consumption as
a sign of anhedonia in muscle-specific PGC-1α-deficient mice
and increased sucrose consumption and decreased immobility
in the forced swim test after chronic mild stress, another model
of despair, in muscle-specific transgenic PGC-1α overexpressing
mice (Agudelo et al., 2014). The authors of this comprehensive
study also reported significantly decreased expression of KATs
in the PGC-1α-deficient animals, enzymes responsible for the
synthesis of KYNA from the TRP metabolite, L-kynurenine, and
argued that a peripheral downregulation of KYNA synthesis
might be responsible for the observed depressive-like behavior
in muscle-specific PGC-1α knockouts. Of note, KYNA is a
neuroprotective end-metabolite of the kynurenine pathway that
TABLE 3 | Assessment of the effect of FL-PGC-1α-deficiency on kynurenic acid synthesis in the murine liver and brain (HPLC).
FL-PGC-1α −/− Wild-type p
Liver
n= 15 16 –
Female/male 7/8 8/8 0.853
KYNA pmol/g ww 154.4 [0.0–173.6] 144.6 [122.2–271.8] 0.495
TRP nmol/g ww 193.2 [61.6–418.2] 170.6 [117.9–398.6] 0.470
KYNA/TRP % 0.09 [0.00–0.23] 0.09 [0.02–0.22] 0.892
Brain
n= 6 8 –
Female/male 0/6 0/8 1.000
KYNA striatum pmol/g ww 41.9 [0.0–157.5] 0.0 [0.0–143.8] 0.662
TRP striatum nmol/g ww 31.8 ± 6.2 22.7 ± 1.5 0.205
KYNA/TRP striatum % 0.10 [0.00–0.77] 0.00 [0.00–0.61] 0.852
KYNA cerebellum pmol/g ww 18.0 ± 9.1 27.7 ± 8.2 0.448
TRP cerebellum nmol/g ww 42.2 ± 6.2 41.2 ± 6.1 0.908
KYNA/TRP cerebellum % 0.02 [0.00–0.12] 0.06 [0.02–0.22] 0.573
KYNA, kynurenic acid; TRP, tryptophan; ww, wet weight.
TABLE 4 | Previous reports on non-motor behavioral alterations of PGC-1α-deficient and transgenic animals.
Publication Strain Behavior Paradigm(s) Findings Age Sex Subject number
Leone et al., 2005 Whole-body
FL-PGC-1α −/−
Anxiety Open-field Thigmotaxis 3.5 m Male n = 11 vs. 8
Agudelo et al., 2014 Muscle-specific
PGC-1α transgenic
Despair Forced-swim test Decreased
immobility after
CMS, no baseline
difference
12–13 w Male n = 8–10
Sucrose consumption Increased after
CMS, no baseline
difference
Muscle-specific
PGC-1α −/−
Sucrose consumption Decreased
(anhedonia)
N/A N/A n = 7–8
Lucas et al., 2014a PV+
neuron-specific
PGC-1α −/−
Hippocampal memory Barnes maze test Increased distance
traveled to reach
the escape box
3 (or 6) m Male n = 11 vs. 6
Bartley et al., 2015 Whole-body
PGC-1α −/−
Hippocampal function Nest building Impaired 2 m Mixed n = 13 vs. 10
PV+
neuron-specific
PGC-1α −/−
Impaired 2–8 m N/A n = 6 vs. 8
CMS, chronic mild stress; m, months; N/A, explicit data not available, w, weeks.
Frontiers in Behavioral Neuroscience | www.frontiersin.org 9 August 2018 | Volume 12 | Article 180
fnbeh-12-00180 August 23, 2018 Time: 20:41 # 10
Szalardy et al. Non-motor Behavior of FL-PGC-1α-Deficient Mice
poorly penetrates the BBB (Fukui et al., 1991) and whose absolute
(Myint et al., 2007; Bay-Richter et al., 2015) or relative levels
(compared to that of a toxic kynurenine metabolite, QUIN, in
form of a ratio) (Savitz et al., 2015) had indeed been found
decreased in the blood of depressed patients. The hypothesis of
the authors was based on the rationale that a decreased peripheral
synthesis of KYNA would allow the relative overrepresentation of
other kynurenine metabolites in the brain that are associated with
higher BBB-penetrance and/or presumed pathogenic roles in
major depression as neurotoxic and neuroinflammatory factors
(Brundin et al., 2016), thereby contributing to the development
of depressive-like symptoms in animals with muscle-specific
PGC-1α deficiency (Agudelo et al., 2014). No direct measures
were, however, published in support of this hypothesis at the
metabolite level. Encouraged by our decades of interest in
kynurenine pathway-related alterations, especially in relation
with neurodegenerative disorders (Zadori et al., 2011; Vecsei
et al., 2013; Veres et al., 2015) and neurocognitive alterations
(Szalardy et al., 2012; Zadori et al., 2018), we measured TRP and
KYNA levels in the liver and different brain regions of whole-
body FL-PGC-1α knockout mice. Our results overall do not
support that PGC-1α deficiency would significantly alter KYNA
synthesis in mice at the metabolite level either in the periphery or
in the CNS, and suggest that other causes should be attributable
to the observed depressive-like phenotype.
To rule out the potential significant bias of muscle weakness
characteristic of these animal strains, we controlled for the
performance of these animals in the wire-hang test conducted
several weeks earlier (a parameter previously demonstrated not
to alter with aging). Of note, the measured time of immobility
in the TST and the latency to fall from the grid did not show
inverse correlation within the PGC-1α-deficient group, likewise,
the ability of the TST performance to distinguish between the
genotypes were not altered significantly by the inclusion of the
wire-hang performance in a binary logistic regression model,
suggesting that muscle weakness on its own cannot be purely
responsible for the despair-like phenotype. Despite all this, the
contribution of muscle weakness to the observed phenomenon
to a certain extent is likely, with the precise value being difficult
to judge.
The previous observation that muscle-specific disruption of
PGC-1α was likewise associated with anhedonic phenotype
irrespective of the muscle function suggests that alterations in
circulatory factors should contribute to the observed despair
behavior. On this basis, it is tempting to speculate that the
observed anhedonic behavior can be also attributed to a form
of ‘sickness behavior’ [as presumed also previously (Agudelo
et al., 2014)], a phenotype suggested to be mediated by increased
circulating levels of IL-6, IL-12, and TNFα penetrating to the
brain (Muller and Schwarz, 2007). Of note, PGC-1α has been
shown to potently decrease the expression of IL-12 in the murine
skeletal muscle (Eisele et al., 2015). Furthermore, a marked
elevation of IL-6 and TNFα have been reported in the serum of
muscle-specific PGC-1α-deficient mice, together with a strong
inverse correlation of PGC-1α mRNA levels with IL-6 and TNFα
gene expression in diabetic human muscles (Handschin et al.,
2007). In addition, PGC-1α overexpression has recently been
shown to downregulate IL-6 expression in astrocytes (Nijland
et al., 2014). These together indeed raise the possibility of a
‘sickness behavior’ underlying the observed despair, however,
the involvement of multiple brainstem structures relevant in
the pathogenesis of depression in the neuropathology present
in these mice definitely renders the identification of the most
prominent cause difficult.
The fact, however, that an effect associates with anxiolytic-like
together with depressive-like patterns is peculiar and unexpected
per se, as these tests most often present concordant findings. Only
few publications can be found reporting similar discordance.
In particular, forebrain-specific disruption of GR in mice lead
to similar anxiety-like performance in the EPM and LDB tests
in association with increased despair in the TST and forced
swim tests, with likewise no alterations in the OF whatsoever,
based on which the authors concluded that different pathways
should mediate these behaviors (Boyle et al., 2006). Interestingly
enough, GR and PGC-1α proteins have been reported to directly
and physically interact with each other, e.g., forming functional
complexes when enhancing the transcription of PEPCK (a
gluconeogenesis gene) (Yoon et al., 2001; Herzog et al., 2004)
or repressing the transcription of the insulin gene (Jang et al.,
2007). In fact, PGC-1α was first discovered in humans as a
potent tissue-specific co-activator of the GR (originally referred
to as LEM6) (Knutti et al., 2000). In addition, glucocorticoids
(such as dexamethasone) are among the most potent inducers
of PGC-1α expression (Knutti et al., 2000; Yoon et al., 2001;
Herzog et al., 2004), further underlying the relevance of a PGC-
1α-GR positive regulatory loop in stress-induced responses, likely
including stress-related behavior. Whether and to what extent
the disruption of this prominent functional connection inside the
CNS could be responsible for the recapitulation of the intriguing
phenotype of forebrain GR-deficient mice, especially in light
of the several structural alterations in the brain of FL-PGC-
1α-deficient mice, is at present unknown.
Finally, a cohort of FL-PGC-1α-deficient mice were subjected
to the two-trial spatial recognition Y-maze test, an established
and sensitive model for spatial memory in rodents (Dellu et al.,
1992, 2000). Previously, PV-positive neuron-specific male PGC-
1α knockout animals have been reported to exhibit deficits in the
Barnes maze test in form of a longer distance traveled to find
the escape box on day 5 after daily training, suggesting deficits
in long-term spatial memory formation, a form of hippocampus-
dependent learning (Lucas et al., 2014a). Subsequently, the same
group reported deficits observed in nest building, an innate
hippocampus-related behavior, in both the whole-body as well
as PV-positive neuron-specific PGC-1α knockout mice, with
no differences reported between males and females, together
indicating impairment in hippocampus-dependent functions
irrespective of sex (Bartley et al., 2015). These findings were
proposed to be not related to hypomotility as, intriguingly,
PV-positive conditional neuron-specific PGC-1α-deficient mice
reported not to exhibit motor impairment (Lucas et al., 2014a;
Bartley et al., 2015). Our results in the two-trial Y-maze test
are not concordant with these prior publications, however,
with no between-cohort differences observed. In fact, FL-PGC-
1α-deficient mice, especially females, provided fairly high median
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preference of the novel arm in the retrieval trial. A limitation
of interpretation is that male FL-PGC-1α-deficient mice showed
somewhat poorer preference, secondary to higher variability in
this group. It is possible that a higher subject number could
have powered up our analysis to provide statistically significant
difference in males; however, we were unfortunately not able to
set up a single cohort at the same time with a higher subject
number, which was already 2–5-times larger than previous
studies reporting hippocampus-based behavioral involvement
in PGC-1α-deficient mice at the cohort level. The excellent
recognition of females and the high upper value of the 95% CI in
males allow as to conclude that FL-PGC-1α-deficiency in general
is not associated with significant impairment in spatial memory
formation. Whether the genotype difference between FL-PGC-
1α-deficiency and complete PGC-1α-deficiency, i.e., the residual
activity of the NT-PGC-1α itself, was capable of rescuing the
phenotype is at present unclear. This in general intact visuospatial
recognition also allows as to suggest that the performance of FL-
PGC-1α-deficient animals in other paradigms are not biased by
possible visual impairment, as supported also by the largely intact
optic nerves (Table 2) and retinal structure (Szalardy et al., 2016a)
in these animals.
CONCLUSION
The present study revisited prior observations of anxiety-
related, depression-related, and hippocampal memory-related
observations made on different PGC-1α-deficient murine strains,
in a large-subject-number analysis on whole-body FL-PGC-
1α-deficient mice. This study is the first in the literature to
address all these non-motor behavioral domains in a single PGC-
1α-deficient strain, with special focus on the potential effect of
age and sex. The findings revealed no signs of previously reported
anxiety-related behavior, but revealed an unexpected, anxiolytic-
like phenotype, consistent throughout different paradigms, with
a slight male preponderance. This was associated with despair-
like anhedonic behavior, consistent with that reported previously,
but did not associate with either peripheral or CNS-related
alterations in KYNA synthesis, which was previously proposed.
Though male FL-PGC-1α-deficient mice tended to perform
poorer in a hippocampus-based spatial learning paradigm, the
genotype overall was not associated with impairment in spatial
memory, contradicting with prior observations. None of the
observed alterations showed age-dependence, similarly to motor
alterations as reported previously (Szalardy et al., 2016a). In
light of the substantial multi-systemic involvement of PGC-1α
deficiency in mice, the provision of exact etiological explanation
for the observed behavioral alterations could not be attempted;
however, the most likely contributors have been addressed and/or
discussed, with clinicopathological correlations drawn. With the
aim to revisit previously published alterations on different PGC-
1α-deficient animals and to complete the phenotypic profiling
of whole-body FL-PGC-1α-deficient mice specifically assessing
non-motor behavioral alterations in light of age and sex, our
findings extend the knowledge about the complex in vivo effect of
PGC-1α dysfunction and add important notes to research in the
field of PGC-1α in connection with neuropsychiatric disorders.
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